{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-032887","form_type":"8-K","ticker":"BCDA","cik":"0000925741","company_name":"BioCardia, Inc.","filed_at":"2026-10-19T13:15:23+00:00","discovered_at":"2026-10-19T13:16:00.617116+00:00","generated_at":"2026-10-19T13:16:05.902375+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioCardia says FDA accepted Helix catheter De Novo pre-submission; review meeting expected this quarter","bullets":["FDA accepted BioCardia's revised De Novo pre-submission package for marketing clearance of the Helix transendocardial delivery catheter, per the Oct. 19, 2026 release.","In May 2026 FDA agreed two pathways exist for Helix clearance and raised no concerns on the product's safety data, performance, or compatibility with general classes of agents.","FDA confirmed the meeting minutes in August 2026; BioCardia revised and resubmitted the package in September 2026 incorporating CDRH advice.","Substantive review with written FDA feedback, followed by a meeting to discuss De Novo approval, is expected this quarter.","Helix data covers 15 clinical trials and nearly 500 patients; clearance could expand partnering with cell, gene and protein therapeutic developers needing heart delivery."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-032887","json":"https://secwatch.observer/filing/0001437749-26-032887.json","markdown":"https://secwatch.observer/filing/0001437749-26-032887.md","text":"https://secwatch.observer/filing/0001437749-26-032887.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/925741/000143774926032887/0001437749-26-032887-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/925741/000143774926032887/bcda20261018_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-19T13:16:05.902375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}